CTBP2 and cancer: They demonstrated that MDSCs triggered miRNA-101 expression in ovarian cancer cells, and miRNA-101 subsequently repressed the corepressor gene C-terminal binding protein-2 (CtBP2), resulting in enhanced cancer cell stemness.